As in NSCLC, there was not a significant association between AMACR and PLIN1 expression and clinical parameters, confirming again that they might be prognostic biomarkers for all patients with SCLC regardless of clinical phenotype. This evidence concerns the gene AMACR and small cell lung carcinoma.